Protalix BioTherapeutics (PLX) Stock Chart & Stock Price History $1.69 +0.06 (+3.68%) (As of 11/20/2024 ET) Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsTrends Protalix BioTherapeutics Stock Price Performance 5 Day Performance+20.71%1 Month Performance+59.43%3 Month Performance+74.24%6 Month Performance+38.52%Year-To-Date Performance-5.06%1 Year Performance+19.86% Receive PLX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Protalix BioTherapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners (Ad)Trump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code… And since then… "In the know" patriots have quietly used this same "Trump revenge loophole" to shield their life savings from Bidenomics…Get Your Free Gold Guide PLX Stock Chart for Thursday, November, 21, 2024 PLX Chart by TradingView Protalix BioTherapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization11/20/2024$1.62$1.69+4.32%$1.74$1.61817,071 shs$124.44 million11/19/2024$1.63$1.62-0.61%$1.74$1.58533,650 shs$119.28 million11/18/2024$1.40$1.63+16.43%$1.72$1.411.79 million shs$119.87 million11/15/2024$1.41$1.39-1.42%$1.41$1.33328,811 shs$102.23 million11/14/2024$1.24$1.41+13.71%$1.41$1.261.45 million shs$103.69 million11/13/2024$1.32$1.24-5.70%$1.31$1.23304,554 shs$91.19 million Get the Latest News and Ratings for PLX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Protalix BioTherapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/12/2024$1.20$1.32+9.58%$1.34$1.21471,457 shs$96.71 million11/11/2024$1.16$1.20+3.45%$1.21$1.18215,084 shs$88.25 million11/08/2024$1.16$1.16$1.22$1.16161,810 shs$85.31 million11/07/2024$1.22$1.16-4.92%$1.24$1.16331,772 shs$85.31 million11/06/2024$1.30$1.22-5.79%$1.33$1.22137,116 shs$89.72 million11/05/2024$1.28$1.30+1.17%$1.32$1.27159,034 shs$95.23 million11/04/2024$1.25$1.28+2.40%$1.36$1.26969,124 shs$94.14 million11/01/2024$1.17$1.25+6.41%$1.26$1.19294,736 shs$91.56 million10/31/2024$1.17$1.17$1.18$1.14113,322 shs$86.05 million10/30/2024$1.18$1.17-0.43%$1.18$1.17135,007 shs$86.05 million10/29/2024$1.13$1.18+3.98%$1.18$1.17127,823 shs$86.41 million10/28/2024$1.08$1.13+4.63%$1.14$1.07236,046 shs$83.10 million10/25/2024$1.03$1.09+5.34%$1.09$1.05129,033 shs$79.79 million10/24/2024$1.02$1.03+0.98%$1.04$1.0248,004 shs$75.75 million10/23/2024$1.06$1.02-3.77%$1.05$1.0287,293 shs$75.01 million10/22/2024$1.06$1.06$1.09$1.01297,333 shs$77.72 million10/21/2024$1.09$1.06-2.75%$1.09$1.05187,585 shs$77.95 million Related Companies Zevra Therapeutics Stock Price Chart Esperion Therapeutics Stock Price Chart REGENXBIO Stock Price Chart Acelyrin Stock Price Chart MeiraGTx Stock Price Chart Xeris Biopharma Stock Price Chart SIGA Technologies Stock Price Chart Cartesian Therapeutics Stock Price Chart Aura Biosciences Stock Price Chart Aquestive Therapeutics Stock Price Chart Receive PLX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Protalix BioTherapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NYSE:PLX) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Protalix BioTherapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Protalix BioTherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
